Fig. 1From: Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemiaTisagenlecleucel survival data presented to experts in evidence dossierBack to article page